Table 3.
Scar group – Cox proportional hazard model, univariate analysis with long-term mortality
| Parameter | p value | HR | CI |
|---|---|---|---|
| Age | <0.0001* | 1.067 | 1.037–1.098 |
| Female gender | 0.0346* | 1.927 | 0.049–3.541 |
| Peripheral artery disease(PAD) | 0.0319* | 2.014 | 1.062–3.816 |
| Glomerular filtration rate(GFR) | 0.0003* | 0.978 | 0.966–0.990 |
| LVEF% | 0.0079* | 0.973 | 0.954–0.993 |
| Number of segments | 0.0040* | 1.164 | 1.049–1.291 |
| Segment group (≥4) | 0.0416* | 1.830 | 1.02–3.3 |
| Scar score | 0.0016* | 4.435 | 1.756–11.202 |
| Number of trans mural segments | 0.0042* | 1.174 | 1.052–1.310 |
| STS mortality risk | <0.0001* | 1.182 | 1.20–1.248 |
MI Myocardial infarction, ACE Angiotensin converting enzyme, CABG Coronary artery bypass graft surgery, LVEDV Left ventricular end diastolic volume, LVESV Left Ventricular End-Systolic Volume, STS society of thoracic surgeons. Asterisk represents variables with significant association